Emerging Markets

Latest Headlines

Latest Headlines

Teva beefs up in emerging markets with $2.3B Rimsa buyout

Last month, names like Sanofi, Pfizer, Abbott and Takeda were flying around as potential suitors for Mexico-based Representaciones e Investigaciones Medicas, aka Rimsa. But it's Teva that's emerged victorious in the field.

Abbott said to expand manufacturing, other operations in India

Abbott Laboratories wlll expand its manufacturing, as well as other operations, in India, though a dollar amount was not given by the pharmaceutical giant.

Merck KGaA counts on Latin America to power consumer-health future

Lately, Latin America has been leading the growth ranks for Merck KGaA's consumer health unit. And that's not set to change anytime soon, its leader says.

Manufacturers' association says pharma contract manufacturing in India growing at 20%

The Indian Drug Manufacturers' Association says the country's pharmaceutical contract manufacturing industry is growing at 20%.

Novartis brings heart, cancer meds to low-income countries for $1 per month

Novartis has stood by its commitment to emerging markets even in rocky times. And now, it's furthering that commitment with an access initiative for low-income countries.

ShangPharma plots a $60M splash for biologics R&D in China

Chinese contract drug developer ShangPharma is planning to invest $60 million to build a biologics research and manufacturing outpost near its home base in Shanghai.

Serum Institute sets out for dengue fast track

Asia's largest vaccinemaker just made a play that could affect the race for a vaccine protecting against dengue fever, a common affliction that has a big impact in the region.

GE Healthcare creates an emerging markets unit with $300M commitment

GE Healthcare has staked a major claim in a field that's not well tended--the development of affordable medical technologies to improve health outcomes in the emerging markets. It's creating a devoted business called Sustainable Healthcare Solutions out of a combination of its operations in India, South Asia, Africa and Southeast Asia dedicated to serving 70 markets--and investing $300 million to back the effort.

LabCorp-backed Ativa gets $15M to bring diagnostics to the doctor's office in emerging markets

The middle class in emerging market countries wants diagnostics--and Minneapolis, MN-based Ativa Medical plans to bring it to them via a point-of-care, micro lab designed for the physician office. The startup has secured a $15 million Series B round that's intended to support gaining FDA approval for its micro lab and preparing for commercial launch.

China's Mindray falls as execs reduce their take-private offer

Mindray Medical was off in early trading on the news that a management buyout that was first proposed in June now has a reduced price. The latest offer was for $27 per ADS; that's down from the original offer of $30 per ADS.